NCT03188510View on ClinicalTrials.gov

A Study of Two Different Formulations of LY3074828 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 30, 2017

Primary Completion Date

November 27, 2017

Study Completion Date

November 27, 2017

Conditions
Healthy
Interventions
BIOLOGICAL

LY3074828

Administered SC

Trial Locations (1)

75247

Covance, Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03188510 - A Study of Two Different Formulations of LY3074828 in Healthy Participants | Biotech Hunter | Biotech Hunter